 Lawrence Cornett
Concepts (123)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Vasopressin | 11 | 2018 | 23 | 1.450 |
Why?
| | Biomedical Research | 3 | 2024 | 237 | 1.260 |
Why?
| | Vasotocin | 9 | 2018 | 14 | 1.250 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 3 | 2013 | 8 | 1.050 |
Why?
| | Chickens | 8 | 2009 | 107 | 0.890 |
Why?
| | Universities | 2 | 2023 | 161 | 0.780 |
Why?
| | Students | 1 | 2023 | 210 | 0.780 |
Why?
| | Birds | 2 | 2013 | 12 | 0.710 |
Why?
| | Mentors | 1 | 2018 | 55 | 0.590 |
Why?
| | Program Development | 1 | 2018 | 166 | 0.570 |
Why?
| | Corticosterone | 2 | 2013 | 18 | 0.530 |
Why?
| | Curriculum | 1 | 2018 | 401 | 0.490 |
Why?
| | Receptors, Adrenergic, beta-2 | 4 | 2012 | 16 | 0.430 |
Why?
| | Corticotropin-Releasing Hormone | 2 | 2013 | 14 | 0.410 |
Why?
| | Cyclic AMP | 4 | 2012 | 90 | 0.380 |
Why?
| | Pituitary Gland | 3 | 2009 | 86 | 0.360 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2008 | 16 | 0.310 |
Why?
| | Cell Membrane | 1 | 2008 | 248 | 0.290 |
Why?
| | Arkansas | 3 | 2023 | 1977 | 0.290 |
Why?
| | Coturnix | 4 | 2018 | 4 | 0.280 |
Why?
| | Photoperiod | 2 | 2018 | 5 | 0.230 |
Why?
| | Anthropology, Cultural | 1 | 2023 | 13 | 0.230 |
Why?
| | Immunization, Secondary | 1 | 2023 | 21 | 0.230 |
Why?
| | Animals | 15 | 2018 | 13187 | 0.200 |
Why?
| | Isoproterenol | 2 | 2012 | 56 | 0.170 |
Why?
| | Adrenergic beta-Agonists | 2 | 2012 | 39 | 0.170 |
Why?
| | Adrenal Glands | 2 | 2009 | 39 | 0.160 |
Why?
| | Oviposition | 4 | 2018 | 10 | 0.150 |
Why?
| | Dimerization | 2 | 2008 | 52 | 0.150 |
Why?
| | Reproduction | 1 | 2018 | 61 | 0.150 |
Why?
| | Signal Transduction | 2 | 2005 | 1618 | 0.150 |
Why?
| | Cloning, Molecular | 4 | 2005 | 185 | 0.150 |
Why?
| | Humans | 13 | 2024 | 49974 | 0.150 |
Why?
| | HeLa Cells | 2 | 2008 | 250 | 0.140 |
Why?
| | Pituitary Gland, Anterior | 2 | 2008 | 37 | 0.140 |
Why?
| | Estrogens | 1 | 2018 | 227 | 0.140 |
Why?
| | Estradiol | 2 | 2008 | 225 | 0.140 |
Why?
| | Phylogeny | 3 | 2005 | 235 | 0.130 |
Why?
| | Amino Acid Sequence | 3 | 2005 | 585 | 0.120 |
Why?
| | Molecular Sequence Data | 3 | 2005 | 792 | 0.120 |
Why?
| | Young Adult | 2 | 2023 | 3958 | 0.110 |
Why?
| | United States | 1 | 2023 | 4860 | 0.110 |
Why?
| | Oxytocin | 2 | 2018 | 19 | 0.110 |
Why?
| | Protein Isoforms | 2 | 2012 | 119 | 0.100 |
Why?
| | Female | 9 | 2023 | 26472 | 0.100 |
Why?
| | In Situ Hybridization | 5 | 2009 | 65 | 0.100 |
Why?
| | Protein Transport | 1 | 2012 | 180 | 0.100 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 181 | 0.100 |
Why?
| | Immunohistochemistry | 6 | 2009 | 973 | 0.090 |
Why?
| | Down-Regulation | 1 | 2012 | 348 | 0.090 |
Why?
| | Adult | 3 | 2023 | 13236 | 0.090 |
Why?
| | Avian Proteins | 1 | 2008 | 4 | 0.080 |
Why?
| | Osmotic Pressure | 1 | 2008 | 10 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2009 | 138 | 0.080 |
Why?
| | Estrogen Receptor Modulators | 1 | 2008 | 5 | 0.080 |
Why?
| | Genitalia, Female | 1 | 2008 | 18 | 0.080 |
Why?
| | Tamoxifen | 3 | 2018 | 60 | 0.080 |
Why?
| | Male | 4 | 2023 | 25241 | 0.080 |
Why?
| | Pyridines | 1 | 2009 | 130 | 0.080 |
Why?
| | Antibodies | 1 | 2008 | 154 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2008 | 170 | 0.070 |
Why?
| | Protein Structure, Tertiary | 1 | 2008 | 253 | 0.070 |
Why?
| | Anti-Inflammatory Agents | 1 | 2009 | 161 | 0.070 |
Why?
| | Microscopy, Fluorescence | 1 | 2008 | 162 | 0.070 |
Why?
| | Luminescent Proteins | 2 | 2005 | 53 | 0.070 |
Why?
| | Uterine Contraction | 1 | 2007 | 37 | 0.070 |
Why?
| | Uterus | 1 | 2007 | 94 | 0.070 |
Why?
| | Protein Binding | 1 | 2008 | 660 | 0.070 |
Why?
| | Receptors, Oxytocin | 1 | 2005 | 4 | 0.070 |
Why?
| | Epidermal Growth Factor | 1 | 2005 | 34 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2005 | 144 | 0.060 |
Why?
| | Bronchi | 1 | 2005 | 43 | 0.060 |
Why?
| | Base Sequence | 2 | 2005 | 643 | 0.060 |
Why?
| | Gene Expression | 2 | 2008 | 609 | 0.060 |
Why?
| | Trihexosylceramides | 1 | 2005 | 3 | 0.060 |
Why?
| | Wound Healing | 1 | 2005 | 204 | 0.060 |
Why?
| | Epithelial Cells | 1 | 2005 | 209 | 0.060 |
Why?
| | Gene Transfer Techniques | 1 | 2003 | 37 | 0.060 |
Why?
| | Adenoviridae | 1 | 2003 | 51 | 0.060 |
Why?
| | Green Fluorescent Proteins | 1 | 2003 | 90 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2005 | 1573 | 0.060 |
Why?
| | Genetic Vectors | 1 | 2003 | 125 | 0.060 |
Why?
| | Second Messenger Systems | 1 | 2003 | 14 | 0.060 |
Why?
| | Sequence Homology | 1 | 2003 | 20 | 0.060 |
Why?
| | Phosphatidylinositols | 1 | 2003 | 27 | 0.060 |
Why?
| | Public Policy | 1 | 2023 | 38 | 0.060 |
Why?
| | COS Cells | 1 | 2003 | 74 | 0.050 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 36 | 0.050 |
Why?
| | Recombinant Proteins | 1 | 2003 | 486 | 0.050 |
Why?
| | Vaccination | 1 | 2023 | 266 | 0.050 |
Why?
| | Calcium | 1 | 2003 | 396 | 0.050 |
Why?
| | Algorithms | 1 | 2024 | 615 | 0.050 |
Why?
| | Rural Population | 1 | 2023 | 540 | 0.040 |
Why?
| | Quail | 1 | 2018 | 1 | 0.040 |
Why?
| | Vasopressins | 1 | 2018 | 39 | 0.040 |
Why?
| | Myometrium | 2 | 2007 | 14 | 0.030 |
Why?
| | Endometrium | 2 | 2007 | 41 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 595 | 0.030 |
Why?
| | Lysosomal-Associated Membrane Protein 1 | 1 | 2012 | 4 | 0.030 |
Why?
| | Adolescent | 1 | 2023 | 6356 | 0.030 |
Why?
| | rab GTP-Binding Proteins | 1 | 2012 | 35 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2012 | 222 | 0.020 |
Why?
| | Gene Expression Regulation | 2 | 2005 | 976 | 0.020 |
Why?
| | Aged | 1 | 2023 | 9310 | 0.020 |
Why?
| | Water Deprivation | 1 | 2008 | 5 | 0.020 |
Why?
| | Sexual Maturation | 1 | 2008 | 14 | 0.020 |
Why?
| | Lactotrophs | 1 | 2008 | 2 | 0.020 |
Why?
| | Corticotrophs | 1 | 2008 | 3 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2008 | 21 | 0.020 |
Why?
| | Middle Aged | 1 | 2023 | 12069 | 0.020 |
Why?
| | Hormones | 1 | 2008 | 55 | 0.020 |
Why?
| | Estrogen Antagonists | 1 | 2007 | 21 | 0.020 |
Why?
| | Organ Size | 1 | 2007 | 226 | 0.020 |
Why?
| | Oligonucleotide Probes | 1 | 2005 | 20 | 0.020 |
Why?
| | Drug Combinations | 1 | 2005 | 123 | 0.020 |
Why?
| | Oligonucleotides | 1 | 2005 | 80 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2005 | 155 | 0.020 |
Why?
| | Body Weight | 1 | 2007 | 513 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2005 | 181 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2007 | 1105 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2005 | 376 | 0.010 |
Why?
| | Rats | 1 | 2008 | 3305 | 0.010 |
Why?
| | Time Factors | 1 | 2007 | 2903 | 0.010 |
Why?
|
|
Cornett's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|